Portfolio (Quarterly)
Guide ↗
GAMMA Investing LLC
· CIK 0002010235| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 4141 | — | INHIBRX INC COM CVR RIGHT from 45720L107 | — | 10.0 | — | — | NEW | — | — | — |
| 4142 | — | ESC GCI LIBERTY INC SHS | — | 14.0 | — | — | NEW | — | — | — |
| 4143 | — | FUSION PHARMACEUTICALS INC CVR from 36118A100 | — | 14.0 | — | — | NEW | — | — | — |
| 4144 | — | SPYGLASS RES CORP COM | — | 31.0 | — | — | NEW | — | — | — |
| 4145 | — | POSEIDA THERAPEUTICS INC COM RIGHT from | — | 42.0 | — | — | NEW | — | — | — |
| 4146 | — | VAPE HLDGS INC COM | — | 45.0 | — | — | NEW | — | — | — |
| 4147 | — | CONSTELLATION SOFTWARE INC WT EXP 033140 | — | 78.0 | — | — | NEW | — | — | — |
| 4148 | — | RESOLUTE FST PRODS INC CVR Right from 76117W109 | — | 92.0 | — | — | NEW | — | — | — |
| 4149 | — | Abiomed Inc USD0 01 SUBS RTS | — | 98.0 | — | — | NEW | — | — | — |
| 4150 | — | LEHMAN BROS HLDGS CAP TR PFD SER M 6 | — | 133.0 | — | — | NEW | — | — | — |
| 4151 | — | ONCOURSE TECHNOLOGIES INC PAR | — | 133.0 | — | — | NEW | — | — | — |
| 4152 | — | CONTRA MIRATI THERAPEU NPV from 60468T105 | — | 223.0 | — | — | NEW | — | — | — |
| 4153 | — | OmniAb Inc USD0 0001 A (USD15 VESTING) | — | 232.0 | — | — | NEW | — | — | — |
| 4154 | — | Cartesian Therapeutics Inc USD0 0001 SUBS RTS | — | 237.0 | — | — | NEW | — | — | — |
| 4155 | — | OmniAb Inc USD0 0001 A (USD12 5 VESTING) | — | 242.0 | — | — | NEW | — | — | — |
| 4156 | — | VERVE THERAPEUTICS INC CVR from 92539P101 | — | 257.0 | — | — | NEW | — | — | — |
| 4157 | — | Blueprint Medicines Corporation NPV | — | 271.0 | — | — | NEW | — | — | — |
| 4158 | — | CONCENTRA BIOSCIENCES LLC NON TRANSFERABLE | — | 292.0 | — | — | NEW | — | — | — |
| 4159 | — | SAGE THERAPEUTICS INC COM CVR from 78667J108 | — | 338.0 | — | — | NEW | — | — | — |
| 4160 | — | AKERO THERAPEUTICS INC CVR from 00973Y108 | — | 452.0 | — | — | NEW | — | — | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
34.8%
Financial Services
12.8%
Industrials
10.5%
Healthcare
9.4%
Consumer Cyclical
9.0%
Communication Services
8.2%
Consumer Defensive
4.8%
Energy
3.7%
Utilities
3.0%
Real Estate
1.9%